Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$319K Sell
4,156
-51
-1% -$3.67K 0.01% 966
2021
Q4
$322K Sell
4,207
-194
-4% -$14.3K 0.01% 914
2021
Q3
$325K Buy
4,401
+191
+5% +$14.3K 0.01% 962
2021
Q2
$281K Buy
4,210
+135
+3% +$9.03K 0.01% 993
2021
Q1
$303K Buy
4,075
+476
+13% +$36.1K 0.01% 947
2020
Q4
$262K Buy
3,599
+1,688
+88% +$119K 0.01% 769
2020
Q3
$127K Buy
1,911
+1,134
+146% +$71.8K 0.01% 891
2020
Q2
$44K Buy
777
+684
+735% +$33.6K ﹤0.01% 942
2020
Q1
$3K Buy
93
+3
+3% +$143 ﹤0.01% 932
2019
Q4
$5K Buy
+90
New +$4.48K ﹤0.01% 725

Other funds holding HOLX

IndexIQ Advisors's HOLX Position: Q1 2022 in Review

IndexIQ Advisors reduced its Hologic (HOLX) stake by 1.2% in Q1 2022, selling an estimated $3.67K and leaving 4,156 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #966.

IndexIQ Advisors first reported a position in HOLX in Q4 2019 and has held it in 10 quarters since. The position peaked at $325K in Q3 2021. 699 funds tracked by Wall St. Rank hold HOLX as of Q1 2022.

  • IndexIQ Advisors held 4,156 shares of Hologic worth $319K as of Q1 2022.
  • IndexIQ Advisors sold 51 Hologic shares in Q1 2022, an estimated $3.67K.
  • Hologic made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #966 holding.
  • IndexIQ Advisors first reported a position in Hologic in Q4 2019 and has held it in 10 quarters since.
  • IndexIQ Advisors's Hologic position peaked at $325K in Q3 2021.
  • 699 funds tracked by Wall St. Rank held Hologic as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.